Miguel Perales MD
@drmiguelperales.bsky.social
Chief Adult BMT MSKCC | Past-President ASTCT | Board Member NMDP | Chair Committee Transplant/Cell Ther ALLIANCE | Immigrant 🇪🇸🇬🇧 #MedSky Opinions mine/not MSK https://www.mskcc.org/cancer-care/doctors/miguel-angel-perales
www.sciencedirect.com/science/arti...
Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma
The approval of CD19 chimeric antigen receptor T-cell (CAR-T) therapy in the second-line (2L) setting for large B-cell lymphoma (LBCL) has reshaped tr…
sciencedirect.com
www.fiercebiotech.com/biotech/jj-a...
J&J axes $5B CAR-T dream months after touting best-in-disease efficacy
Johnson & Johnson has dropped a pair | Johnson & Johnson has dropped a pair of CAR-T cell therapies, axing programs it once predicted could deliver peak sales north of $5 billion.
fiercebiotech.com
After being treated for Hodgkin lymphoma, Ethan Zohn works to educate people on the benefits of physical activity during care. Read his story in Cancer Today magazine. buff.ly/9p0wnYS @ethanzohn.bsky.social @drmiguelperales.bsky.social
EBMT 2026 is around the corner! 🔜 #EBMT26 Join thousands of HCP's in #Madrid 🇪🇸 from 22-25 March 2026. 🤩 📍 Attend in person 🎫 Get a Day Pass 💻 Or join virtually Register here ➡️🔗 https://www.ebmt.org/annual-meeting-2026
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine www.nytimes.com/2026/02/18/h...
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
nytimes.com
Predicting chronic graft-versus-host disease This issue’s cover features work by Sophie Paczesny @sophpacz.bsky.social & team on BIOPREVENT, a tree-based machine learning algorithm developed using data from 1,310 recipients of hematopoietic cell transplants: doi.org/10.1172/JCI1...
Remember: In the prevaccine era, measles would peak in late winter- early spring. Don’t be surprised if in the next few weeks we see a surge www.aol.com/articles/us-...
4 times as many measles cases in few weeks than US typically averages in year: CDC
There have been 733 cases so far this year, a CDC report said.
aol.com
🎉 Congrats to Luis Diaz Jr., MD, on receiving the 2026 Gustave Roussy Award - Honored for groundbreaking work in precision oncology. 👉https://lfdn.org/3NXPdIs #ResearchIsFundamental @mskcancercenter.bsky.social @gustaveroussy.fr
Join global experts at the 2026 Tandem Meetings to explore the biological mechanisms driving acute and chronic GVHD, the latest clinical research and novel therapeutic approaches. Register today to attend these sessions: www.tandemmeetings.com
As part of the GVHD Alliance community, ASTCT is proud to raise awareness and connect people with trusted GVHD resources. Learn more about GVHD and explore available resources as we prepare for GVHD Day on February 17. www.gvhdalliance.org/resources/ #GVHDDay #GVHDAlliance #StrongerThanGVHD
Great presentation by my colleague Heather Landau on transformative results of BCMA #CARTcells for #amyloidosis #tandem26 @mskcancercenter.bsky.social @mskdeptofmed.bsky.social
In a "Best Abstracts" session at #Tandem26, Dr. Heather Landau will present the study, "First 23-Patient Safety and Efficacy Data from Nexicart-2, the First U.S. Trial of CAR-T in R/R Light Chain (AL) Amyloidosis, Nxc-201." @mskcancercenter.bsky.social 📍 Feb 6, 9:15 a.m. MST https://bit.ly/46sXtGv
My Op Ed in Today's Washington Post: "The long-lasting effects of viruses — and the anti-vaccine movement. For some people, a viral infection can have devastating long-term effects." wapo.st/4qjFtWk
What's next for HCT and cellular therapies? The #Tandem26 opening-day plenary examined progress from breakthrough to bedside — looking toward equitable access and improved care. Read more in Tandem Meeting News: www.tandemmeetingsnews.com/joint-plenar...
🏆 NMDP is proud to receive the ASTCT Public Service Award at #Tandem2026, with CEO Amy Ronneberg recognized on behalf of our org. Since 1987, NMDP has advanced transplantation & access to cell therapy—impacting 140,000+ lives. We thank ASTCT for recognizing that commitment with a meaningful honor!
Don't miss Dr. Moneeza Walji's #Tandem26 presentation, "Improved Social Drivers of Health: Support through a Novel Needs Assessment and Patient Navigation Program for Bone Marrow Transplant and Cellular Therapy Patients." 📍Feb 4, 4:30 p.m. ➡️ https://bit.ly/3ZS2zsc @mskcancercenter.bsky.social
#Tandem26: Dr. Natalia Tijaro Ovalle will present the results of a phase 2 study evaluating precision melphalan dosing combined with siltuximab in older adults with #multiplemyeloma undergoing stem cell transplant. 📍Feb 5, 4:15 p.m. MST ➡️ https://bit.ly/49ZW3pn @mskcancercenter.bsky.social
Coming up at #Tandem26: Bone marrow transplant specialist & cellular therapist Dr. Brian Shaffer will moderate the plenary session, "Innovations in GVHD Prevention: PTCy & Beyond." 📍 Feb. 5, 5:00 – 6:30 p.m. MST | Salt Palace Convention Center, Ballroom AB. @mskcancercenter.bsky.social
Plenary session to examine latest advances to prevent GVHD - Tandem Meetings News
Brian Shaffer, MD, previews a session on cyclophosphamide, gut microbiota and T-cell depleted transplantation.
tandemmeetingsnews.com
Celebrating @cibmtr.bsky.social Mary Horowitz on her retirement. It has been a privilege to work with her and learn from her over the years. Truly a giant in our field, a generous colleague and good friend.
Congrats to Dr. Miguel-Angel Perales, Chief of the Adult Bone Marrow Transplant Service at @mskcancercenter.bsky.social, on being inducted into the 2026 Class of the American Society of Transplantation and Cellular Therapy Fellows Program!@drmiguelperales.bsky.social #Tandem26 📷: @astct.bsky.social
Roisin E. O'Cearbhaill, MD How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors? #tandem26 journals.lww.com/journalppo/f...
journals.lww.com
My @mskcancercenter.bsky.social colleague Dr Roisin E. O'Cearbhaill discussing role of cell therapy at #tandem26 Joint session @astct.bsky.social @sitcancer.bsky.social #tcellrx #cartcells
Congratulations to our 2026 Fellows of ASTCT (FASTCT) and past presidents Dr. Corey Cutler and Dr. Miguel-Angel Perales! #Tandem26 @drmiguelperales.bsky.social
At #Tandem26, don't miss Dr. Mohammad Alhomoud's presentation, "Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study." 📍 Feb 4, 4:15 PM MST ➡️ https://bit.ly/49XCUEv @mskcancercenter.bsky.social
Dewolf et al @mskcancercenter.bsky.social #tandem26 pubmed.ncbi.nlm.nih.gov/37494469/
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse - PubMed
T cells are the central drivers of many inflammatory diseases, but the repertoire of tissue-resident T cells at sites of pathology in human organs remains poorly understood. We examined the site-specificity of T cell receptor (TCR) repertoires across tissues (5 to 18 tissues per patient) in prospect …
pubmed.ncbi.nlm.nih.gov
